Page last updated: 2024-08-23

etoposide and Cystadenocarcinoma, Mucinous

etoposide has been researched along with Cystadenocarcinoma, Mucinous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, X; Itamochi, H; Kanamori, Y; Kigawa, J; Minagawa, Y; Oishi, T; Okada, M; Terakawa, N	1

Other Studies

1 other study(ies) available for etoposide and Cystadenocarcinoma, Mucinous

Article	Year
Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer. Cancer, 1998, Feb-15, Volume: 82, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Cisplatin; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Treatment Outcome	1998

Article

Year

Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer.

Cancer, 1998, Feb-15, Volume: 82, Issue:4

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Cisplatin; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Treatment Outcome

1998